News

Fierce Biotech11d
Boehringer boards B-cell depletion bandwagon, paying Cue $12M to line up autoimmune attack
Boehringer Ingelheim has joined the surge of companies entering the B-cell depletion space. But while its peers have largely ...
B cells found to be crucial for long-term vaccine protection
Researchers at the University of Colorado Anschutz Medical Campus have uncovered a critical, previously underappreciated role ...
BioPharma Dive1d
Caribou, in reversal, scraps autoimmune cell therapy and cuts staff
The CRISPR company is laying off about a third of its employees and stopping work on an experimental lupus treatment in a bid ...
EurekAlert!12d
Lupus Research Alliance grants Lupus Innovation Awards to eleven talented researchers to accelerate pace of discovery in lupus research
The Lupus Research Alliance (LRA) is proud to announce the recipients of this year’s Lupus Innovation Award (LIA), addressing many critical themes in lupus research including novel therapeutic ...
Fierce Biotech1d
Caribou cuts 32% of staff, further purges pipeline to focus on 2 oncology CAR-T prospects
The pipeline purge comes less than a year after Caribou cut 12% of staff and ended its natural killer cell therapy program in ...
Science Daily13d
FDA clears IND for clinical trial testing switchable CAR-T therapy in patients with autoimmune diseases, without chemotherapy
FDA has cleared an investigational new drug (IND) application to study switchable chimeric antigen receptor T cell (sCAR-T) therapy (CLBR001 + SWI019) in patients with autoimmune conditions. Patient ...